Nepal: Covid-19 Vaccine Request Debate
Full Debate: Read Full DebateLord Campbell-Savours
Main Page: Lord Campbell-Savours (Labour - Life peer)Department Debates - View all Lord Campbell-Savours's debates with the Foreign, Commonwealth & Development Office
(3 years, 7 months ago)
Lords ChamberMy Lords, I return the compliment by paying tribute to my noble friend for his work and his advocacy for Nepal. I can also further assure him that this morning I met with the Minister for the Armed Forces, and the MoD is standing up a military, medical and advisory team on the ground to assess. They will be leaving early next week to assess the requirements on the ground. I am directly engaging with the Government of Nepal. Indeed, I had a very constructive meeting with the Foreign Minister yesterday, establishing exactly what the key requirements are, and later this afternoon I will be meeting the Nepalese ambassador to the Court of St James to further discuss issues of logistics. We have already extended support, including funding an oxygen generation plant at the Nepal Police Hospital, and we are working on the ground through our embassy, and with officials within the FCDO and the MoD, to see what further support can be extended at the earliest opportunity.
My Lords, despite the work of COVAX, is not the absence of an effective international vaccine manufacturing and distribution system that meets world demand perfectly illustrated by Nepal’s reported difficulties, particularly when the Serum Institute of India, the world’s largest manufacturer, is situated in Pune, in the state of Maharashtra in India, next door to Nepal? With an 8 billion world population at risk and potentially only a 4 billion worldwide double -dosage manufacturing capacity, as yet unrealised, how can world demand be met?
The challenges—the noble Lord mentioned the Serum Institute of India, which I know well as the Minister for India, and the challenges in India in terms of the current wave sweeping across the country—are well known. We have seen a stepping up in terms of manufacturing and collaboration, and the United Kingdom’s structured approach to the COVAX facility demonstrates the importance, as the noble Lord himself acknowledges, of a global supply chain which guarantees the distribution of Covid-19 vaccines across the world.